Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

281 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Not Yet Recruiting

Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How Well it Works in Patients With Severe Hemophilia A in India

NCT07446010

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Department of Medicine Assam Medical College & Hospital Dibrugarh, India
  • Government of Medical College Kozhikode Kozhikode, India
  • Sanjay Gandhi Post Graduate Institute & Medical Sciences Lucknow, India
  • Christian Medical College & Hospital Ludhiana, India
View Trial Details
Completed

A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

NCT05147662

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Children, +9 more
Locations
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
  • Hospital de Niños Sor María Ludovica La Plata, Buenos Aires, Argentina
  • Instituo Hematología Arbesú Godoy Cruz, Mendoza Province, Argentina
  • Instituto de Hematología Dr. Rubén Dávoli Rosario, Santa Fe Province, Argentina
View all 18 locations
View Trial Details
Completed

Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A

NCT06579144

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Sobi Investigational Site Sofia, Bulgaria
  • Sobi Investigational Site Bonn, Germany
  • Sobi Investigational site Frankfurt, Germany
  • Sobi Investigational Site Milan, Italy
View Trial Details
Completed

Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants

NCT03315455

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • Xiangya Hospital of Centre-South University Changsha, China
  • Southern Medical University Nanfang Hospital Guangdong Province Guangzhou City, China
View all 13 locations
View Trial Details

Related conditions